BiotechTube
Home/PharmaMar/Arturo T. Galvani
AT

Arturo T. Galvani

Director of Research and Development

PharmaMar

Therapeutic Areas

Oncology

PharmaMar Pipeline

DrugIndicationPhase
Zepzelca (lurbinectedin)Relapsed Small Cell Lung CancerPhase 3
PM14Advanced Solid TumorsPhase 1/2
Aplidin (plitidepsin)Relapsed/Refractory Multiple MyelomaApproved (Conditional - AU)
Ecubectedin (PM54)Advanced Solid TumorsPhase 1
Yondelis (trabectedin)Soft Tissue SarcomaApproved

Leadership Team at PharmaMar

JM
José María Fernández Sousa-Faro
Founder, President & CEO
PG
Pablo G. Salinas
General Manager & Chief Medical Officer
LM
Luis Mora
Chief Financial Officer
AG
Alfonso G. Fernández
Chief Operating Officer
View full PharmaMar profile